Does the transdermal route undergo first-pass metabolism? An in-depth pharmacological guide
•
4 min read
The first transdermal patch was approved by the U.S. FDA in 1979 for motion sickness, ushering in a new era of drug delivery. Unlike oral medications that are subject to hepatic breakdown, transdermal drug delivery inherently bypasses and therefore does not undergo first-pass metabolism.
